Objectives/Hypothesis: An estimated 500,000 patients per year in the United
States. are affected by stroke-related dysphagia. Approximately half exper
ience aspiration, which can lead to pneumonia or death. Aspiration may resu
lt from many factors, including delayed transport of the bolus, faulty lary
ngeal elevation, and poor coordination or inappropriate timing of vocal cor
d closure. Interventions carried out to protect the lungs are usually irrev
ersible, destructive to the upper airway, and rarely prevent the need for e
nteral tube feeding. Study Design: We present a report of the first implant
ations of a new device in an FDA-approved study to restore dynamic laryngot
racheal separation. Two stroke patients needing tracheostomy were selected
based on chronic aspiration verified by clinical and radiologic criteria (m
odified barium swallow [MBS]). Methods: The left recurrent laryngeal nerve
was exposed and electrically stimulated to verify vocal fold adduction. Hun
tington Medical Research Institute Bipolar Helical Electrodes were then imp
lanted around the nerve. The leads were tunneled and linked to a NeuroContr
ol(TM) Implantable Receiver-Stimulator placed subcutaneously on the chest w
all. Activation of the stimulator was performed through an external transmi
tter linked by induction. Results. The device was successfully triggered in
tra- and postoperatively. Serial flexible fiberoptic endoscopies and MBS de
monstrate that aspiration is systematically arrested using low levels of el
ectrical stimulation (42 Hz, 48-100 mu sec, 1 mA). Discussion: This pioneer
ing work has shown that aspiration can be controlled without airway damage
for a wide population of neurologically impaired patients because it appear
s more physiological than standard therapies. Conclusion: Based on the firs
t two patients, paced laryngotracheal separation is clinically effective in
controlling aspiration.